Blog
About

1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Antiarrhythmic therapy is commonly used for suppression of arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) in conjunction with implantable cardioverter-defibrillators and catheter ablation. The efficacy of combination flecainide and sotalol/metoprolol therapy for patients refractory to single agents and/or catheter ablation has not been well established.

          Related collections

          Author and article information

          Journal
          Heart Rhythm
          Heart rhythm
          Elsevier BV
          1556-3871
          1547-5271
          Apr 2017
          : 14
          : 4
          Affiliations
          [1 ] Division of Cardiovascular Medicine, University of California-San Francisco, San Francisco, California. Electronic address: Simon.Ermakov@ucsf.edu.
          [2 ] Division of Cardiovascular Medicine, University of California-San Francisco, San Francisco, California.
          Article
          S1547-5271(16)31166-3
          10.1016/j.hrthm.2016.12.010
          27939893

          Comments

          Comment on this article